Click here to close now.




















Welcome!

News Feed Item

JSS Medical Research Inc. and Integrated Research Inc. in Montréal, Québec, Canada completes the strategic merger of the two companies to become the largest Canadian owned CRO

MONTREAL, Jan. 7, 2014 /PRNewswire/ - JSS Medical Research Inc. (JSS), a full-service international Contract Research Organization (CRO), announced today that it has completed the acquisition of Integrated Research Inc. (IRI), a Canadian CRO located in Dollard-des-Ormeaux, Quebec. The transaction results in the strategic merger of the two companies with IRI continuing to operate as a fully-owned subsidiary of JSS.

IRI was founded over two decades ago by Joanne E. Watson M.Sc. and it provides clinical research support to pharmaceutical, device, and biotechnology companies. The company's core service offering includes study start-up, project management, site management, data management, and monitoring covering a wide range of therapeutic areas. With clinical operations as its foundation, and owing to its in-depth knowledge and understanding of regulatory matters, and extensive network of experienced clinical researchers, IRI has become a leading Canadian CRO with an impeccable reputation for providing the highest quality of comprehensive and flexible study management.

JSS Medical Research was also founded approximately twenty years ago by Dr. John S. Sampalis a Clinical Epidemiologist from McGill University. Clinical Research, Medical Science, Epidemiology and Biostatistics were the cornerstones of the foundation of JSS. Clinical Operations were incorporated on the scientific foundation and hence the company evolved as a fully integrated CRO offering services that include strategic consulting, study conceptualization, study design, protocol development, execution, project management, site management, monitoring, data management, biostatistical consulting and analysis, and medical writing. The company has earned an international reputation as one of the leading scientific CROs with significant expertise in pre- and post-approval epidemiological studies.

"This is an important milestone for JSS and IRI as well as for the Canadian Industry. The merger of JSS and IRI creates a robust and stable Canadian based and owned CRO that has the critical mass, expertise and most importantly, experienced senior management that will offer highest quality services covering all of the scientific and operational aspects of clinical research. Now a local CRO will be able to provide the same services as the large multinationals, while maintaining the intimate client relationships that have contributed to our longevity and client loyalty over the last twenty years" stated Dr. John S. Sampalis, CEO and President of JSS Medical Research.

"For our international and global clients, the merger with IRI, in combination with the recent acquisition of Latam Clinical Trials, provides significant advantages. We now have augmented our operational and regulatory expertise across several jurisdictions and expanded the clinical research team to allow us to easily manage our local and international studies. In addition, our clients will benefit from our Quality Assurance Program which has been audited and tested by several of our global clients" said Ms. Stella Boukas, V.P. Clinical Operations of JSS.

"From a financial perspective, the synergies of JSS and IRI will provide our clients with a stronger CRO that can address all of their service needs with conservative costs. In the current CRO market where costs are an important second consideration for the selection of service providers, JSS-IRI will offer competitive pricing at uncompromised quality. At the same time the merger of the two companies will reduce overhead and other costs and will contribute to our continued financial stability and growth" stated Dr. Toni Rinow, CFO of JSS.

"Widespread adoption of outsourcing has changed the clinical services landscape over the past five years with strategic relationships with the 10 large CROs dominating the market. Smaller CROs have to adapt their business strategies to meet the changing needs of sponsors. JSS Medical Research has pursued its journey in becoming a niche provider in late phase studies by excelling in scientific methods for conducting research. We have gained strategic advantage as market leader in Post Marketing Observational Studies, Health Economic Outcome Research and a proven track record in medical writing, publications and presentations at scientific conferences. The merger with IRI will strengthen our position in Canada and provide the foundation for our continued expansion while at the same time enabling us to continue to deliver high quality research to our Canadian and international clients" said Dr. Sanjay Machado, Executive Director Global Business Operations of JSS.

"In an industry that is both dynamic and volatile, our growth strategy is driven by the demands and the needs of our clients. More specifically, our expansion in Latin America, which began with the acquisition of Latam and will continue with others in Chile, Argentina and Brazil, has resulted from the increasing requirements for epidemiological and post marketing studies by regional health authorities and payers in these regions. The merger with IRI has also been driven by the need for a Canadian CRO that can provide comprehensive high quality turnkey services to the Canadian Affiliates of International Pharmaceuticals and Canadian biotech companies. Integrated Research's philosophy with emphasis on high quality clinical operations governed by integrity and responsiveness to their clients was entirely compatible with the JSS Medical Research's vision" concluded Dr. Sampalis.

"The pace of growth at JSS Medical Research sees us joining a company at a very exciting time and being part of this group will enable us to better leverage our expertise, offering our local and international clients access to additional complementary services provided by senior personnel with the highest possible level of scientific expertise and knowledge in clinical trial operations," said Joanne Watson, founder and CEO of Integrated Research. "Both companies' business ethic is focused on a commitment to excellence and quality and this philosophy is only further reinforced by the combination of the two organizations."

About JSS Medical Research

JSS Medical Research is a full-service CRO with its corporate office in Montreal, Canada and a regional office in Colombia. The company offers clinical trial management services in Phase I-IV trials in a broad range of therapeutic areas and is a leader in Post-Approval Clinical Epidemiology Studies (PACES) including Post-Marketing Observational Studies, Health Outcomes Research and Health Economics. Personalized services with one-on-one client attention from experienced senior scientific and clinical teams have established JSS Medical Research as a unique niche CRO worldwide. Currently JSS Medical Research is conducting research studies in over 20 countries around the world for its clients which include the top 20 global pharmaceutical companies.

www.jssresearch.com.

About Integrated Research Inc.

Integrated Research Inc. is a Canadian contract research organization providing clinical research management services and expert assistance to pharmaceutical and biotechnology firms worldwide in the development of their therapeutic agents.  Headquartered in Montreal, its highly skilled team offers a complete range of services and guidance in Phase II, III, and IV studies, post-marketing surveillance programs, and Investigator-driven research initiatives. For over 21 years, IRI has prided itself on meeting the challenges of research by providing innovative solutions along with the flexibility and professionalism you expect when outsourcing your clinical research needs.

SOURCE JSS Medical Research Inc.

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
"We've just seen a huge influx of new partners coming into our ecosystem, and partners building unique offerings on top of our API set," explained Seth Bostock, Chief Executive Officer at IndependenceIT, in this SYS-CON.tv interview at 16th Cloud Expo, held June 9-11, 2015, at the Javits Center in New York City.
Mobile, social, Big Data, and cloud have fundamentally changed the way we live. “Anytime, anywhere” access to data and information is no longer a luxury; it’s a requirement, in both our personal and professional lives. For IT organizations, this means pressure has never been greater to deliver meaningful services to the business and customers.
Digital Transformation is the ultimate goal of cloud computing and related initiatives. The phrase is certainly not a precise one, and as subject to hand-waving and distortion as any high-falutin' terminology in the world of information technology. Yet it is an excellent choice of words to describe what enterprise IT—and by extension, organizations in general—should be working to achieve. Digital Transformation means: handling all the data types being found and created in the organizat...
SYS-CON Events announced today that HPM Networks will exhibit at the 17th International Cloud Expo®, which will take place on November 3–5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. For 20 years, HPM Networks has been integrating technology solutions that solve complex business challenges. HPM Networks has designed solutions for both SMB and enterprise customers throughout the San Francisco Bay Area.
Chuck Piluso presented a study of cloud adoption trends and the power and flexibility of IBM Power and Pureflex cloud solutions. Prior to Secure Infrastructure and Services, Mr. Piluso founded North American Telecommunication Corporation, a facilities-based Competitive Local Exchange Carrier licensed by the Public Service Commission in 10 states, serving as the company's chairman and president from 1997 to 2000. Between 1990 and 1997, Mr. Piluso served as chairman & founder of International Te...
The Software Defined Data Center (SDDC), which enables organizations to seamlessly run in a hybrid cloud model (public + private cloud), is here to stay. IDC estimates that the software-defined networking market will be valued at $3.7 billion by 2016. Security is a key component and benefit of the SDDC, and offers an opportunity to build security 'from the ground up' and weave it into the environment from day one. In his session at 16th Cloud Expo, Reuven Harrison, CTO and Co-Founder of Tufin,...
Container technology is sending shock waves through the world of cloud computing. Heralded as the 'next big thing,' containers provide software owners a consistent way to package their software and dependencies while infrastructure operators benefit from a standard way to deploy and run them. Containers present new challenges for tracking usage due to their dynamic nature. They can also be deployed to bare metal, virtual machines and various cloud platforms. How do software owners track the usag...
SYS-CON Events announced today that MobiDev, a software development company, will exhibit at the 17th International Cloud Expo®, which will take place November 3–5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. MobiDev is a software development company with representative offices in Atlanta (US), Sheffield (UK) and Würzburg (Germany); and development centers in Ukraine. Since 2009 it has grown from a small group of passionate engineers and business managers to a full-scale mobi...
With SaaS use rampant across organizations, how can IT departments track company data and maintain security? More and more departments are commissioning their own solutions and bypassing IT. A cloud environment is amorphous and powerful, allowing you to set up solutions for all of your user needs: document sharing and collaboration, mobile access, e-mail, even industry-specific applications. In his session at 16th Cloud Expo, Shawn Mills, President and a founder of Green House Data, discussed h...
For IoT to grow as quickly as analyst firms’ project, a lot is going to fall on developers to quickly bring applications to market. But the lack of a standard development platform threatens to slow growth and make application development more time consuming and costly, much like we’ve seen in the mobile space. In his session at @ThingsExpo, Mike Weiner, Product Manager of the Omega DevCloud with KORE Telematics Inc., discussed the evolving requirements for developers as IoT matures and conducte...
There are many considerations when moving applications from on-premise to cloud. It is critical to understand the benefits and also challenges of this migration. A successful migration will result in lower Total Cost of Ownership, yet offer the same or higher level of robustness. In his session at 15th Cloud Expo, Michael Meiner, an Engineering Director at Oracle, Corporation, analyzed a range of cloud offerings (IaaS, PaaS, SaaS) and discussed the benefits/challenges of migrating to each offe...
One of the hottest areas in cloud right now is DRaaS and related offerings. In his session at 16th Cloud Expo, Dale Levesque, Disaster Recovery Product Manager with Windstream's Cloud and Data Center Marketing team, will discuss the benefits of the cloud model, which far outweigh the traditional approach, and how enterprises need to ensure that their needs are properly being met.
In their session at 17th Cloud Expo, Hal Schwartz, CEO of Secure Infrastructure & Services (SIAS), and Chuck Paolillo, CTO of Secure Infrastructure & Services (SIAS), provide a study of cloud adoption trends and the power and flexibility of IBM Power and Pureflex cloud solutions. In his role as CEO of Secure Infrastructure & Services (SIAS), Hal Schwartz provides leadership and direction for the company.
In a recent research, analyst firm IDC found that the average cost of a critical application failure is $500,000 to $1 million per hour and the average total cost of unplanned application downtime is $1.25 billion to $2.5 billion per year for Fortune 1000 companies. In addition to the findings on the cost of the downtime, the research also highlighted best practices for development, testing, application support, infrastructure, and operations teams.
The Internet of Everything (IoE) brings together people, process, data and things to make networked connections more relevant and valuable than ever before – transforming information into knowledge and knowledge into wisdom. IoE creates new capabilities, richer experiences, and unprecedented opportunities to improve business and government operations, decision making and mission support capabilities.